Gold nanoparticles bring scientists closer to a treatment for cancer

Key points
- Scientists at the University of Southampton have developed smart nanomaterials, which can disrupt the blood supply to cancerous tumours.
- The team of researchers, led by Physics lecturer Dr Antonios Kanaras, showed that a small dose of gold nanoparticles can activate or inhibit genes that are involved in angiogenesis - a complex process responsible for the supply of oxygen and nutrients to most types of cancer.
- "The peptide-functionalised gold nanoparticles that we synthesised are very effective in the deliberate activation or inhibition of angiogenic genes," said Dr Kanaras.
- The team went a step further to control the degree of damage to the endothelial cells using laser illumination.
Scientists at the University of Southampton have developed smart nanomaterials, which can disrupt the blood supply to cancerous tumours.
The team of researchers, led by Physics lecturer Dr Antonios Kanaras, showed that a small dose of gold nanoparticles can activate or inhibit genes that are involved in angiogenesis - a complex process responsible for the supply of oxygen and nutrients to most types of cancer.
"The peptide-functionalised gold nanoparticles that we synthesised are very effective in the deliberate activation or inhibition of angiogenic genes," said Dr Kanaras.
The team went a step further to control the degree of damage to the endothelial cells using laser illumination. Endothelial cells construct the interior of blood vessels and play a pivotal role in angiogenesis.
The researchers also found that the gold particles could be used as effective tools in cellular nanosurgery.
Dr Kanaras adds: "We have found that gold nanoparticles can have a dual role in cellular manipulation. Applying laser irradiation, we can use the nanoparticles either to destroy endothelial cells, as a measure to cut the blood supply to tumours, or to deliberately open up the cellular membrane in order to deliver a drug efficiently."
The researchers have published two related papers (NanoLett. 2011, 11 (3), 1358 - Small 2011, 7, No. 3, 388) with another one submitted for publication and four more planned throughout this year. Their major target is to develop a complete nanotechnology toolkit to manipulate angiogenesis.
###
Contact: Glenn Harris
[email protected]
44-023-805-93212
University of Southampton
Written and revised by
David Cohen, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Cancer →
NewsScientists map risk of premature menopause after cancer treatment
Women treated for the cancer Hodgkin lymphoma will be able to better understand their risks of future infertility after researchers estimated their risk of premature menopause with different treatments. The findings,…
24 August 2014
NewsBrain tumor causes and risk factors elude scientists
Today, nearly 700,000 people in the U.S. are living with a brain tumor, and yet, when it comes to pinpointing causes or risk factors, scientists are still searching for answers. "Right now, we don't know who, we don't…
27 July 2014
NewsScientists find new way to combat drug resistance in skin cancer
RAPID RESISTANCE to vemurafenib - a treatment for a type of advanced melanoma, the deadliest form of skin cancer - could be prevented by blocking a druggable family of proteins, according to research* published in…






